Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2009
10/15/2009WO2009124931A2 Amino acid sequences directed against the notch pathways and uses thereof
10/15/2009WO2009124815A1 Agent for treating disease
10/15/2009WO2009124381A1 An anti-cancer cytotoxic monoclonal antibody
10/15/2009WO2009124378A1 Chimeric anti-measles antibody
10/15/2009WO2009103969A4 Synthetic scfv analogue to the 6313/g2 (anti angiotensin ii type 1 receptor) monoclonal antibody variable regions
10/15/2009WO2009103862A3 Method for detecting mitotic cells
10/15/2009WO2009077744A3 Vaccines for brucellosis
10/15/2009WO2009044158A3 Inhibitors and uses
10/15/2009WO2008140477A9 Hybrid immunoglobulins with moving parts
10/15/2009WO2008096158A8 Antibody single variable domains against serum albumin
10/15/2009US20090260094 Stearoyl-CoA Desaturase 4 Gene
10/15/2009US20090259031 CHIMERIC AND HUMANIZED ANTIBODIES TO alpha5beta1 INTEGRIN THAT MODULATE ANGIOGENESIS
10/15/2009US20090259028 Prevention of leaching of ligands from affinity-based purification systems
10/15/2009US20090259027 Human GM-CSF antibodies
10/15/2009US20090259026 Ligand
10/15/2009US20090259022 Cdna encoding the human alpha2 delta4 calcium channel subunit
10/15/2009US20090259019 Masp-2, a complement fixing enzyme, and uses for it
10/15/2009US20090258826 Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use
10/15/2009US20090258442 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
10/15/2009US20090258436 Reagents for the Detection of Protein Phosphorylation in Signaling Pathways
10/15/2009US20090258426 Preferred segments of neural thread protein and method of using the same
10/15/2009US20090258424 Cellular Delivery of siRNA
10/15/2009US20090258420 Altered polypeptides, immunoconjugates thereof, and methods related thereto
10/15/2009US20090258409 Purified sr-p70 protein
10/15/2009US20090258396 Crustaceans as production systems for therapeutic proteins
10/15/2009US20090258393 Single chain class i major histocompatibility complexes, constructs encoding same and methods of generating same
10/15/2009US20090258390 Prokaryotic collagen-like proteins and uses thereof
10/15/2009US20090258380 Perhydrolase Epitopes
10/15/2009US20090258358 Methods for Diagnosing and Treating Kidney and Colorectal Cancer
10/15/2009US20090258357 identifying a binding partner to a cytokine receptor common gamma chain like (CRCGCL) polypeptide encoded by a cDNA; for diagnosis and treatment autoimmune disorders
10/15/2009US20090258079 Biocompatible Block Copolymer, Use Thereof and Manufacturing Method Thereof
10/15/2009US20090258064 Compositions of ucp inhibitors, fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor
10/15/2009US20090258026 Anti-notch1 nrr antibodies and methods using same
10/15/2009US20090258023 Tgf-beta superfamily binding proteins and modulation of bone formation and loss
10/15/2009US20090258022 protein comprising signal transduction domain for use in treatment and prevention of nervous system disorders; immunizing a mammal with a protein comprising the sequence of SEQ ID NO:2
10/15/2009US20090258021 Genes associated with mechanical stress, expression products therefrom, and uses thereof
10/15/2009US20090258020 Antibody designated barb3, barb3 related antibodies, and methods of making and using same
10/15/2009US20090258019 Diagnosis of carcinoma using RAIG1 polypeptides
10/15/2009US20090258013 Novel compositions and methods for the treatment of immune related diseases
10/15/2009US20090258012 Compositions and methods for treating inflammatory disorders
10/15/2009US20090258011 Antibodies against west nile virus and therapeutic and prophylactic uses thereof
10/15/2009US20090258009 Protofibril selective antibodies and the use thereof
10/15/2009US20090258008 Uses of the FcRn Receptor
10/15/2009US20090258007 Anti-Perp Antibody
10/15/2009US20090258005 Therapeutic compositions and methods
10/15/2009US20090258004 Human blood proteins expressed in monocot seeds
10/15/2009CA2721052A1 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
10/15/2009CA2720887A1 Inhibitors of stim1 for the treatment of cardiovascular disorders
10/15/2009CA2720763A1 Amino acid sequences directed against the notch pathways and uses thereof
10/15/2009CA2720748A1 Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (dnl) technology
10/15/2009CA2720614A1 Neutralization of gm-csf for the treatment of heart failure
10/15/2009CA2720104A1 Method of discriminating bovine, thus discriminated bovine and kit for discriminating bovine
10/15/2009CA2719924A1 Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
10/15/2009CA2719189A1 Novel compositions and methods for the treatment of immune related diseases
10/15/2009CA2718975A1 Compositions and methods for detecting egfr mutations in cancer
10/15/2009CA2718191A1 Agent for treating disease
10/15/2009CA2710398A1 Methods and compositions for targeting polyubiquitin
10/14/2009EP2108660A1 Inhibition of IL-17 production
10/14/2009EP2108658A1 Uses of IL-23 agonists and antagonists; related reagents
10/14/2009EP2108376A2 Prevention and treatment of amyloidogenic disease
10/14/2009EP2108044A2 Sub -population of hematopoietic stem cells that express the crisp-1 protein
10/14/2009EP1881008A9 Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody
10/14/2009EP1680449B1 Non-human transgenic mammal for the constant region of the class a human immunoglobulin heavy chain and applications therof
10/14/2009EP1554572B1 Compositions and methods for modulating blood-brain barrier transport
10/14/2009EP1488240B1 Detection of specific nitrated markers
10/14/2009EP1450845B1 15603, a human ion channel family member
10/14/2009EP1432737B1 Human mini-antibody cytotoxic for tumor cells which express the erbb2 receptor
10/14/2009EP1356046B1 Cytokine receptor zcytor19
10/14/2009EP1339750B1 Process for selecting anti-angiogenesis antibody fragments
10/14/2009EP1304375B1 Method of preparing antibody by gene immunization
10/14/2009EP1230268B1 Heteroclitic analogs of class i epitopes
10/14/2009EP1227843B1 Method and system to remove cytokine inhibitor in patients
10/14/2009EP1144447B1 Tuberculosis diagnostic test
10/14/2009CN101558308A Methods of treating, diagnosing or detecting cancer
10/14/2009CN101558082A Targeted binding agents directed to PDGFR-alpha and uses thereof
10/14/2009CN101557799A Liquid anti-rabies antibody formulations
10/14/2009CN101555512A Preparation method for monoclonal antibody specifically binding vardenafil and analog thereof
10/14/2009CN101555484A Recombinant human HMBOX1 expression vector, expression production thereof and antibody and application thereof
10/14/2009CN101555483A Echinococcus granulosus EgFABP-Eg95 polypeptide and preparation and application of recombinant brevibacterium vaccine thereof
10/14/2009CN101555477A Heavy and light chain variable region gene of monoclonal antibody resisting human amyloid
10/14/2009CN101555283A Antibodies to non-functional p2x7 receptor, diagnosis and treatment of cancers and other conditions
10/14/2009CN101555282A Antibody of fucosylated Golgi protein GP73 and use thereof
10/14/2009CN101555281A Preparation method of anti-influenza A H1N1 virus specific IgY and related formulation thereof
10/14/2009CN101555234A Method for preparing cyanide-urea triamide hapten, artificial antigen and antibody as well as application thereof
10/14/2009CN100549165C Calcineurin of clonorchis sinensis, its coding nucleic acid and application
10/14/2009CN100549164C Recombinant virus comprising tumor therapeutic full-antibody gene with human constant region and its use
10/14/2009CN100549031C Mutated nonactivating IgG2 domains and anti-cd3 antibodies incorporating same
10/14/2009CN100548374C Combination therapy with class III anti-CEA monoclonal antibodies and therapeutic agents
10/13/2009US7601891 Optimizing glycan processing of a plant cell containing glycoproteins with hybrid or complex type N-glycanscontaining a galactose residue on one arm of the N-glycan and which are devoid or reduced in xylose and fucose residues; genetic engineering; hybrid enzymes; drugs
10/13/2009US7601889 Cucleic acid cotnaining a specific nucleotide sequence which encodes a polypeptide which elongates alpha -linolenic acid by two or more carbon atoms whereas gamma -lino-lenic is not elongated
10/13/2009US7601825 Administering to cancer cells a vector that encodes a single chain monoclonal antibody that immunospecifically binds to an 121P1F1-related protein
10/13/2009US7601818 Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
10/13/2009US7601817 For treating a disease medicated by TNF alpha including acute and chronic immune and immunoregulatory disorders and rheumatoid or osteo-arthritis
10/13/2009US7601816 Transcripts harboring inton 1, or fragment thereof; preventing or treating Alzheimer's Disease; ameliorating a neurodegenerative condition; modulating amyloid precursor protein; selectively inhibiting COX-3 or PCOX-1a activity
10/13/2009US7601815 For controlling development, differentiation, trafficking, and physiology of mammalian cells; diagnosis
10/13/2009US7601814 Reduce binding to epitope to fusion protein; reduce its ability to interact with a T cell receptor; use in immunotherapy
10/13/2009US7601813 Anti-GL50 antibodies
10/13/2009US7601812 Schistosoma protein for use in treatment of organ-specific autoimmune diseases
10/13/2009US7601809 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs
10/13/2009US7601804 immunogens for treating cattle diseases; biodrugs for veterinary medicine